% Expired Patents = 42.9

EPO Patents = 1

Forward Citations = 69

Loading Chart...

2 inventors (with patents filed for the assignee):

Henry William Lupton (7 out of 16 patents)

Mark Bruzzi (3 out of 22 patents)

Henry William Lupton (0 patent)

7 patents: Sort by Forward Citations

1. 9974930 - Guide wire for use in re-canalising a vascular occlusion in a human or animal subject (2018-05-22),

2. 9802026 - Guide wire for use in re-canalising a vascular occlusion in a human or animal subject (2017-10-31),

3. 8764684 - Guide wire for use with a catheter (2014-07-01),

4. 8500656 - Guide wire for use with a catheter (2013-08-06),

5. 8262589 - Guide wire for use with a catheter (2012-09-11),

6. 8092395 - Guide wire for use in re-canalising a vascular occlusion in a human or animal subject (2012-01-10),

7. 7789839 - Guide wire for use with a catheter (2010-09-07),

Company Overview

Brivant Research & Development Limited is a leading provider of innovative research and development solutions. We specialize in creating cutting-edge technologies for various industries, including healthcare, finance, and telecommunications. With a team of experienced professionals, we are committed to delivering high-quality services and products to our clients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#25 in Galway

#252 in Ireland

Galway, Ireland

Brivant Research & Development Limited

Forward Citations = 69

2 inventors:

Henry William Lupton (7 out of 16 patents)

Mark Bruzzi (3 out of 22 patents)

Henry William Lupton (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Brivant Research & Development Limited. Retrieved from https://idiyas.com/company/brivant-research-and-development

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]